<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Hiccups and dopamine

descriptionPublicationkeyboard_double_arrow_right Article 15 Nov 2008 English Publisher:Oxford University Press (OUP)Journal:American Journal of Health-System Pharmacy, volume 65, pages 2,092-2,094 (issn: 1079-2082, eissn: 1535-2900,

Authors: Georg Petroianu; Anka Stegmeier-Petroianu;

doi: 10.2146/ajhp080128

pmid: 18997134

Hiccups and dopamine

- Summary
- Subjects
- Metrics

Abstract

Lertxundi et al.[1][1] should be commended for reminding readers of the therapeutic complexities in using antidopaminergic agents in Parkinson’s disease (PD). We wish to comment on the etiology and treatment of hiccups. The authors’ statement that anti-dopaminergic therapy is needed for hiccups

Related Organizations

United Arab Emirates University
United Arab Emirates

Keywords

Antiparkinson Agents, Pramipexole, Dopamine Agonists, Amantadine, Dopamine Antagonists, Humans, Perphenazine, Parkinson Disease, Benzothiazoles, Hiccup

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average